Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

News > All

Total search results: 11812 | Ordered by Date (descending)
1 2 3 ... 117 118 119  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
SparingVision. (10/21/20). "Press Release: SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer". Paris. 2020-10-21
Centogene N.V.. (10/20/20). "Press Release: Centogene Announces Leadership Transition". Cambridge, MA & Rostock. 2020-10-20
Proteintech Group, Inc.. (10/20/20). "Press Release: Proteintech Acquires ChromoTek, Expanding its Next Generation Antibody Tools". Chicago, IL & Munich. 2020-10-20
Atbtherapeutics. (10/20/20). "Press Release: Atbtherapeutics Strengthens Its Scientific Advisory Board to Support the Development of its Novel Platform and Portfolio". Belgium. 2020-10-20
Precigen, Inc.. (10/20/20). "Press Release: Precigen Strengthens Focus on Strategic Partnerships and Names Gaurav Vij Head of Business Development". Germantown, MD. 2020-10-20
ProteoNic B.V.. (10/20/20). "Press Release: ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics". Leiden. 2020-10-20
BioSpecifics Technologies Corporation. (10/19/20). "Press Release: BioSpecifics to be Acquired by Endo Pharmaceuticals". Wilmington, DE. 2020-10-19
Topas Therapeutics GmbH. (10/19/20). "Press Release: Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief Executive Officer". Hamburg. 2020-10-19
VectivBio AG. (10/15/20). "Press Release: VectivBio Closes $110 Million Crossover Financing to Advance Transformational Medicines for Rare Diseases". Basel. 2020-10-15
Precigen, Inc.. (10/15/20). "Press Release: Precigen’s UltraPorator Receives FDA Clearance for Manufacturing UltraCAR-T Cells in Clinical Trials". Germantown, MD. 2020-10-15
Bayer AG. (10/15/20). "Press Release: Leaps by Bayer Leads USD 17 Million Series B Financing in Biotech Company Azitra". Leverkusen & Branford, CT. 2020-10-15
Astellas Pharma Inc.. (10/15/20). "Press Release: Astellas to Acquire Iota Biosciences". Tokyo & Berkeley, CA. 2020-10-15
Galapagos N.V.. (10/15/20). "Press Release: Galapagos and Servier Report Topline Results for ROCCELLA Phase 2 Clinical Trial with GLPG1972/S201086 in Knee Osteoarthritis Patients". Mechelen & Paris. 2020-10-15
Consilium Strategic Communications Ltd.. (10/15/20). "Press Release: Consilium Strategic Communications Advises Compass Pathways on Its Successful Initial Public Offering". London. 2020-10-15
Johnson & Johnson. (10/14/20). "Press Release: Janssen Japan President Chris Hourigan Named New Company Group Chairman for Janssen Asia Pacific". Singapore. 2020-10-14
RayzeBio, Inc.. (10/14/20). "Press Release: RayzeBio Launches with $45 Million Series A to Advance Portfolio of Targeted Radiopharmaceuticals for Cancer Therapeutics". San Diego, CA. 2020-10-14
Oncopeptides AB. (10/14/20). "Press Release: Oncopeptides Signs € 40 Million Loan Agreement with the EIB". Stockholm. 2020-10-14
Ori Biotech Ltd.. (10/14/20). "Press Release: Ori Biotech Raises $30 Million in Series A Financing to Advance Innovation in Cell and Gene Therapy Manufacturing". London & Woodcliff Lake, NJ. 2020-10-14
Polyphor Ltd.. (10/14/20). "Press Release: Polyphor Receives CARB-X Award of up to USD 18.44 Million to Support Development of New Antibiotic Program". Allschwil. 2020-10-14
Qiagen N.V.. (10/13/20). "Press Release: Qiagen Reports Strong Preliminary Results for Third Quarter of 2020". Venlo. 2020-10-13
MorphoSys AG. (10/13/20). "Press Release: MorphoSys AG Successfully Places EUR 325 Million Convertible Bonds [Not for US, AU, ZA, JP, et al.]". Planegg. 2020-10-13
Evotec SE. (10/13/20). "Press Release: Mubdala Investment Company and Novo Holdings A/S Invest €250m in Evotec SE". Hamburg. 2020-10-13
Chord Therapeutics S.A.. (10/13/20). "Press Release: Chord Therapeutics Launches with USD 16 Million Series A Financing from Omega Funds". 2020-10-13
Oxurion N.V.. (10/13/20). "Press Release: Oxurion NV Appoints Tom Graney, CFA as Chief Financial Officer". Leuven & Boston, MA. 2020-10-13
Twist Bioscience Corporation. (10/13/20). "Press Release: Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies". South San Francisco, CA, Amsterdam & New York, NY. 2020-10-13
Rappta Therapeutics Oy. (10/13/20). "Press Release: Rappta Therapeutics Raises Series A Financing for the Development of Phosphatase 2A Drugs". Helsinki. 2020-10-13
MorphoSys AG. (10/13/20). "Press Release: Ad hoc – MorphoSys AG Launches an Offering of approx. EUR 325 Million Convertible Bonds". Planegg. 2020-10-13
Axol Bioscience Ltd.. (10/13/20). "Press Release: Axol Bioscience Introduces Multi-electrode Array Screening Services for Human iPSC-derived Cells". Cambridge. 2020-10-13
Merck KGaA. (10/12/20). "Press Release: Merck Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA". Darmstadt. 2020-10-12
Priothera Ltd.. (10/12/20). "Press Release: Priothera Closes €30 Million Series A Financing to Develop Highly Promising Therapies for Acute Myeloid Leukemia (AML)". Dublin. 2020-10-12
BioNTech SE. (10/9/20). "Press Release: Pfizer Canada and BioNTech Initiate Rolling Submission to Health Canada for SARS-CoV-2 Vaccine Candidate BNT162b2". Kirkland, QC & Mainz. 2020-10-09
Precigen, Inc.. (10/9/20). "Press Release: Precigen Announces Merck KGaA, Darmstadt, Germany Increases Ownership Position Through Exercise of Convertible Note". Germantown, MD. 2020-10-09
Merck KGaA. (10/8/20). "Press Release: Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant". Darmstadt. 2020-10-08
Relief Therapeutics Holding AG. (10/8/20). "Press Release: Relief Therapeutics Appoints Industry Veteran, Jack Weinstein, as Chief Financial Officer and Treasurer". Geneva. 2020-10-08
Kronos Bio, Inc.. (10/8/20). "Press Release: Kronos Bio Announces Pricing of Initial Public Offering". San Mateo, CA & Cambridge, MA. 2020-10-08
Evotec SE. (10/8/20). "Press Release: Evotec Achieves Milestone in Neurodegeneration Collaboration with Bristol Myers Squibb". Hamburg. 2020-10-08
Sensei Biotherapeutics, Inc.. (10/7/20). "Press Release: Sensei Biotherapeutics Announces $28.5 Million Financing To Advance Clinical Pipeline and Immunophage Platform Targeting Multiple Cancers". Boston, MA & Gaithersburg, MD. 2020-10-07
Biocartis Group N.V.. (10/6/20). "Press Release: Biocartis Announces Market Release of SeptiCyte RAPID Test on Idylla". Mechelen. 2020-10-06
Ynsect S.A.S.. (10/6/20). "Press Release: Agtech Startup Ÿnsect Extends Its Series C to $372 Million to Improve Global Food Security and Sustainability with the First Carbon Negative and Largest Vertical Farm in the World". Paris. 2020-10-06
Argenx SE. (10/6/20). "Press Release: Argenx Expands Capabilities In Antibody Engineering Through Key Technology Partnerships". Breda & Ghent. 2020-10-06
Sirion Biotech GmbH. (10/6/20). "Press Release: Mustang Bio Licenses LentiBOOST Technology from Sirion Biotech for the Development of MB-207 Lentiviral Gene Therapy". Worcester, MA & Martinsried. 2020-10-06
BioNTech SE. (10/6/20). "Press Release: BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2". New York, NY & Mainz. 2020-10-06
Nvidia Corporation. (10/5/20). "Press Release: Nvidia Announces Partnership with GSK’s AI-Powered Lab for Discovery of Medicines and Vaccines". Santa Clara, CA. 2020-10-05
10x Genomics Inc.. (10/5/20). "Press Release: 10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions". Pleasanton, CA. 2020-10-05
Nvidia Corporation. (10/5/20). "Press Release: Nvidia Building UK’s Most Powerful Supercomputer, Dedicated to AI Research in Healthcare". Santa Clara, CA. 2020-10-05
Qiagen N.V.. (10/5/20). "Press Release: Qiagen to Complement COVID-19 Testing Portfolio with Novel Kit that Simplifies and Accelerates PCR Analysis for Research Applications". Hilden & Germantown, MD. 2020-10-05
Centre for Research on Multinational Corporations (SOMO). (10/2/20). "Press Release: New Research Reveals Large-scale Tax Avoidance by Coronavirus Test Manufacturer Qiagen". 2020-10-02
Vaccibody AS. (10/1/20). "Press Release: Vaccibody Enters into Worldwide License and Collaboration Agreement with Genentech, a Member of the Roche Group, to Develop Individualized Neoantigen Cancer Vaccines". Oslo. 2020-10-01
Kaleido Biosciences, Inc.. (10/1/20). "Press Release: Kaleido Biosciences Appoints Daniel Menichella as President and Chief Executive Officer". Lexington, MA. 2020-10-01
Sophia Genetics S.A.. (10/1/20). "Press Release: Sophia Genetics Raises $110 Million in Oversubscribed New Funding Round". Lausanne & Boston, MA. 2020-10-01
MorphoSys AG. (9/30/20). "Press Release: MorphoSys Announces Departure of Jens Holstein, CFO, by Year End 2020". Planegg. 2020-09-30
Sonoma Biotherapeutics Inc.. (9/30/20). "Press Release: Sonoma Biotherapeutics Expands Series A Financing to $70 Million and Appoints Key Executives to Advance Regulatory T-cell Therapies in Autoimmune and Degenerative Diseases". South San Francisco, CA 2020-09-30
Bruker Corporation. (9/30/20). "Press Release: Bruker Announces Acquisition of Integrated Proteomics Pipeline (IP2) Software Platform for Large Cohort Translational Studies". Billerica, MA. 2020-09-30
Dewpoint Therapeutics. (9/29/20). "Press Release: Dewpoint Therapeutics Raises $77M Series B Financing to Advance the Development of Drugs that Target Biomolecular Condensates". Boston, MA. 2020-09-29
CureVac N.V.. (9/29/20). "Press Release: CureVac Initiates Phase 2a Clinical Trial of COVID-19 Vaccine Candidate. Study Conducted in Peru and Panama". Tübingen & Boston, MA. 2020-09-29
Immatics N.V.. (9/29/20). "Press Release: Immatics Appoints Arnd Christ as Chief Financial Officer". Tübingen & Houston, TX. 2020-09-29
Merck KGaA. (9/29/20). "Press Release: Press Release as a Result of the Ad-hoc Announcement of September 29, 2020". Darmstadt. 2020-09-29
Orphazyme A/S. (9/29/20). "Press Release: Orphazyme Prices Its Global Offering, Consisting of an Initial Public Offering of ADSs in the U.S. and a Concurrent Private Placement of Ordinary Shares in Europe". Copenhagen. 2020-09-29
BaseLaunch (BaselArea.swiss). (9/28/20). "Press Release: BaseLaunch Announces that Johnson & Johnson Innovation Has Renewed Its Commitment Becoming Latest Strategic Partner in the Second Phase". Basel. 2020-09-28
Merck KGaA. (9/28/20). "Press Release: Stefan Oschmann to Hand Over Chair of Executive Board to Belén Garijo in 2021". Darmstadt. 2020-09-28
Ipsen S.A.. (9/25/20). "Press Release: Ipsen Appoints Philippe Lopes-Fernandes as Executive Vice President, Chief Business Officer". Paris. 2020-09-25
Galecto, Inc.. (9/25/20). "Press Release: Galecto Raises $64 Million to Accelerate Development of Clinical Pipeline". Boston, MA & Copenhagen. 2020-09-25
BioInnovation Institute (BII). (9/24/20). "Press Release: BioInnovation Institute Partners with Eight International VCs". Copenhagen. 2020-09-24
Monte Rosa Therapeutics. (9/24/20). "Press Release: Monte Rosa Therapeutics Announces $96 Million Series B Financing to Advance Small Molecule-based Protein Degradation Platform". Boston, MA. 2020-09-24
Enterome S.A.. (9/23/20). "Press Release: Enterome Announces First Patient Dosed in Phase 2a Trial of Sibofimloc in Crohn’s Disease". Paris & Cambridge, MA. 2020-09-23
Libra Therapeutics, Inc.. (9/23/20). "Press Release: Libra Launches with $29M Series A to Develop Novel Therapeutics for Neurodegenerative Diseases". San Diego, CA. 2020-09-23
Minaris Regnerative Medicine GmbH. (9/23/20). "Press Release: Hitachi Chemical’s Global Regenerative Medicine Business Renamed Minaris Regenerative Medicine". Allendale, NJ, Munich & Yokohama. 2020-09-23
MacDougall Advisors, Inc.. (9/22/20). "Press Release: MacDougall Names New Managing Partners". Natick, MA. 2020-09-22
Salvia BioElectronics B.V.. (9/22/20). "Press Release: Salvia BioElectronics Raises EUR 26M (USD 31M) to Develop Innovative Neurostimulation Therapy for Chronic Migraine". Eindhoven. 2020-09-22
Medicxi Ventures. (9/22/20). "Press Release: Medicxi Announces the Closing of Its First €200 Million Secondary Fund, Led by Pantheon with Co-lead LGT Capital Partners". London, Geneva & Jersey. 2020-09-22
ERS Genomics Ltd.. (9/22/20). "Press Release: ERS Genomics Appoints Michael Arciero as Vice-President of Intellectual Property & Commercial Development". Dublin. 2020-09-22
Athira Pharma, Inc.. (9/22/20). "Press Release: Athira Pharma Announces Closing of Initial Public Offering". Seattle, WA. 2020-09-22
Illumina, Inc.. (9/21/20). "Press Release: Illumina to Acquire Grail to Launch New Era of Cancer Detection". San Diego, CA & Menlo Park, CA. 2020-09-21
T-Knife GmbH. (9/21/20). "Press Release: T-Knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell Therapy". Berlin & Somerset, NJ. 2020-09-21
Immune Regulation Ltd.. (9/21/20). "Press Release: Immune Regulation Limited Raises £40.6 Million / $53.4 Million Series B Equity Financing". London & Boston, MA. 2020-09-21
Compass Pathways plc. (9/18/20). "Press Release: Compass Pathways Announces Pricing of Upsized Initial Public Offering". London. 2020-09-18
BioNTech SE. (9/17/20). "Press Release: BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021". Mainz. 2020-09-17
InflaRx N.V.. (9/17/20). "Press Release: InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strategy Officer". Jena. 2020-09-17
Qiagen N.V.. (9/17/20). "Press Release: Qiagen Fully Acquires NeuMoDx Molecular, Inc., Rounding Out Portfolio of PCR-based Diagnostic Automation Systems". Hilden & Ann Arbor, MI. 2020-09-17
Athira Pharma, Inc.. (9/17/20). "Press Release: Athira Pharma Announces Pricing of Initial Public Offering". Seattle, WA. 2020-09-17
Boehringer Ingelheim. (9/17/20). "Press Release: Boehringer Ingelheim and Mirati Therapeutics Annonce Clinical Collaboration to Study BI 1701963, a SOS1::pan-KRAS Inhibitor in Combination with MRTX849, a KRAS G12C Selective Inhibitor". Ingelheim & San Di 2020-09-17
Novo Holdings A/S. (9/17/20). "Press Release: Novo Ventures Co-leads US$83m Series C Financing in Lava Therapeutics". Copenhagen. 2020-09-17
Polyneuron Pharmaceuticals AG. (9/16/20). "Press Release: Polyneuron Extends Series A to CHF 36.5 Million with Additional CHF 14 Million". Basel. 2020-09-16
Graphite Bio. (9/16/20). "Press Release: Graphite Bio Launches with $45 Million Series A Financing". South San Francisco, CA. 2020-09-16
Moderna, Inc.. (9/16/20). "Press Release: Moderna Announces First Commercial Organization Outside North America in Switzerland". Cambridge, MA. 2020-09-16
Dinaqor AG. (9/16/20). "Press Release: Dinaqor AG Appoints Eduard Ayuso as Chief Technology Officer". Pfäffikon. 2020-09-16
Immatics N.V.. (9/15/20). "Press Release: Immatics Appoints Biotech Executive Eliot Forster to Board of Directors". Tübingen & Houston, TX. 2020-09-15
Amadeus Capital Partners. (9/15/20). "Press Release: Amadeus Appoints New Partners Edward Kliphuis and Kai Schmitz". London & Bogotá. 2020-09-15
BioNTech SE. (9/15/20). "Press Release: BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162". Mainz. 2020-09-15
Onyx Health. (9/15/20). "Press Release: Onyx Health Launches International PR Partnership with US Agency Jeff Winton Associates". 2020-09-15
10x Genomics Inc.. (9/15/20). "Press Release: 10x Genomics Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares". Pleasanton, CA. 2020-09-15
ERS Genomics Ltd.. (9/14/20). "Press Release: ERS Genomics Provides Comment on US Patent Office Motions Decisions in CRISPR/Cas9 Interference Case". Dublin. 2020-09-14
Proteome Sciences plc. (9/14/20). "Press Release: Appointment of Chief Executive Officer". 2020-09-14
Neogene Therapeutics, Inc.. (9/14/20). "Press Release: Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies". New York, NY & Amsterdam. 2020-09-14
Boehringer Ingelheim. (9/11/20). "Press Release: Boehringer Ingelheim and Click Therapeutics Enter into Collaboration to Develop and Commercialize CT-155, a Novel Prescription Digital Therapeutic to Aid in the Treatment of Schizophrenia". Ingelheim & New 2020-09-11
Bruker Corporation. (9/11/20). "Press Release: Bruker Announces Acquisition of Canopy Biosciences, LLC". Billerica, MA. 2020-09-11
Korro Bio, Inc.. (9/10/20). "Press Release: Korro Bio Closes $91.5 Million Series A Financing to Advance the Next Frontier in RNA Therapeutics". Cambridge, MA. 2020-09-10
Gain Therapeutics, Inc.. (9/10/20). "Press Release: Gain Therapeutics Announces Research Collaboration with Sumitomo Dainippon Pharma Co., Ltd to Advance Gain’s Lysosomal Enzyme Allosteric Regulator Program". Bethesda, MD. 2020-09-10
Bayer AG. (9/10/20). "Press Release: Bayer – Supervisory Board Extends CEO Werner Baumann’s Contract until the End of April 2024. Company also Announces Progress in Roundup Settlements". Leverkusen. 2020-09-10
Atbtherapeutics. (9/9/20). "Press Release: Atbtherapeutics Appoints Dr Werner Cautreels and Dr Vincent Brichard to Its Board of Directors to Foster Development of Its Game-changing Antibody-toxin Bioengineered ‘Atbody’ Therapeutics". Belgium. 2020-09-09
1 2 3 ... 117 118 119  next pagenext page



Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top